Champions Oncology (CSBR) Capital Leases (2018)
Champions Oncology's (CSBR) quarterly Capital Leases came in at $95000.0 in Q4 2018, down 35.81% on a QoQ basis from $148000.0 in Q3 2018.
Powered by 
Analysis
Champions Oncology (CSBR) Capital Leases (2018) Analysis & Trends
Champions Oncology (CSBR) has 1 years of Capital Leases data on file, last reported at $95000.0 in Q4 2018.
- On a quarterly basis, Capital Leases changed N/A year-over-year to $95000.0 in Q4 2018; TTM through Oct 2018 was $95000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $17000.0, changed N/A from the prior year.
- Capital Leases for Q4 2018 stood at $95000.0, down from $148000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $148000.0 in Q3 2018 and bottomed at $17000.0 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2018 | 95,000.00 |
| Jul 31, 2018 | 148,000.00 |
| Apr 30, 2018 | 17,000.00 |